| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 10,970 | $30 | $285.3K |
| J0897 | Injection, denosumab, 1 mg | 8,580 | $20 | $154.5K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 5,000 | $20 | $80K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 680 | $110 | $73.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 340 | $120 | $41.8K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 40,500 | $1 | $40.5K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 4,200 | $10 | $25.2K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 480 | $30 | $12.4K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 60 | $190 | $12.2K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 170 | $60 | $10.4K |